Visfatin, a potential biomarker and prognostic factor for endometrial cancer

Gynecologic Oncology

Volumn 129, Issue 3, 2013, Pages 505-512

  Tian, Wenyan ^a   Zhu, Yuanxi ^a   Wang, Yingmei ^a   Teng, Fei ^a   Zhang, Huiying ^a   Liu, Guoyan ^a,b   Ma, Xuegong ^a   Sun, Dandan ^a   Rohan, Thomas ^c   Xue, Fengxia ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adipocytokine; Biomarker; Endometrial cancer; Prognostic factor; Visfatin

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR MARKER;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR INVASION;

CASE-CONTROL STUDIES; CYTOKINES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84877574703     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.02.022     Document Type: Article

References (28)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. C.M. Friedenreich, R.K. Biel, D.C. Lau, I. Csizmadi, K.S. Courneya, and A.M. Magliocco Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 20 2011 2384 2395
3. S. Braun, K. Bitton-Worms, and D. LeRoith The link between the metabolic syndrome and cancer Int J Biol Sci 7 2011 1003 1015
4. M. Galli, F. Van Gool, A. Rongvaux, F. Andris, and O. Leo The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer Cancer Res 70 2010 8 11
5. S. Pilz, H. Mangge, B. Obermayer-Pietsch, and W. Marz Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions J Endocrinol Invest 30 2007 138 144
6. M. Dalamaga, S. Archondakis, G. Sotiropoulos, K. Karmaniolas, N. Pelekanos, and E. Papadavid Could serum visfatin be a potential biomarker for postmenopausal breast cancer? Maturitas 71 2012 301 308
7. T.E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, T. Matsuda, and S. Fujita Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer Cancer Sci 101 2010 1286 1291
8. N. Mu, Y. Zhu, Y. Wang, H. Zhang, and F. Xue Insulin resistance: a significant risk factor of endometrial cancer Gynecol Oncol 125 2012 751 757
9. L.Q. Zhang, D.P. Heruth, and S.Q. Ye Nicotinamide phosphoribosyltransferase in human diseases J Bioanal Biomed 3 2011 13 25
10. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, and K. Kishimoto Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430
11. S.T. Patel, T. Mistry, J.E. Brown, J.E. Digby, R. Adya, and K.M. Desai A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis Peptides 31 2010 51 57
12. T.E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, T. Gotoda, and H. Katai Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer J Gastroenterol 44 2009 685 690
13. Y. Wang, S. Hua, W. Tian, L. Zhang, J. Zhao, and H. Zhang Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent Gynecol Oncol 125 2012 734 741
14. Y. Wang, Y. Zhu, L. Zhang, W. Tian, S. Hua, and J. Zhao Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway Cancer Lett 322 2012 223 231
15. W. Creasman Revised FIGO staging for carcinoma of the endometrium Int J Gynaecol Obstet 105 2009 109
16. V. Rosato, A. Zucchetto, C. Bosetti, L. Dal Maso, M. Montella, and C. Pelucchi Metabolic syndrome and endometrial cancer risk Ann Oncol 22 2011 884 889
17. N. Mu, Y. Zhu, Y. Wang, H. Zhang, and F. Xue Insulin resistance: a significant risk factor of endometrial cancer Gynecol Oncol 125 2012 751 757
18. R.E. Schmandt, D.A. Iglesias, N.N. Co, and K.H. Lu Understanding obesity and endometrial cancer risk: opportunities for prevention Am J Obstet Gynecol 205 2011 518 525
19. N. Mu, Y. Wang, and F. Xue Metformin: a potential novel endometrial cancer therapy Int J Gynecol Cancer 22 2012 181
20. M. Dalamaga, K. Karmaniolas, E. Papadavid, N. Pelekanos, G. Sotiropoulos, and A. Lekka Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters Menopause 18 2011 1198 1204
21. S.E. Hufton, P.T. Moerkerk, R. Brandwijk, A.P. de Bruine, J.W. Arends, and H.R. Hoogenboom A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization FEBS Lett 463 1999 77 82
22. J.R. Van Beijnum, P.T. Moerkerk, A.J. Gerbers, A.P. De Bruine, J.W. Arends, and H.R. Hoogenboom Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer Int J Cancer 101 2002 118 127
23. R.E. Shackelford, M.M. Bui, D. Coppola, and A. Hakam Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers Int J Clin Exp Pathol 3 2010 522 527
24. Y.C. Lee, Y.H. Yang, J.H. Su, H.L. Chang, M.F. Hou, and S.S. Yuan High visfatin expression in breast cancer tissue is associated with poor survival Cancer Epidemiol Biomarkers Prev 20 2011 1892 1901
25. M.A. Folgueira, D.M. Carraro, H. Brentani, D.F. Patrao, E.M. Barbosa, and M.M. Netto E SP, Goes JC, Brentani MM. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer Clin Cancer Res 11 2005 7434 7443
26. Y. Li, Y. Zhang, B. Dorweiler, D. Cui, T. Wang, and C.W. Woo Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism J Biol Chem 283 2008 34833 34843
27. J.G. Kim, E.O. Kim, B.R. Jeong, Y.J. Min, J.W. Park, and E.S. Kim Visfatin stimulates proliferation of MCF-7 human breast cancer cells Mol Cells 30 2010 341 345
28. A. Garten, S. Petzold, A. Korner, S. Imai, and W. Kiess Nampt: linking NAD biology, metabolism and cancer Trends Endocrinol Metab 20 2009 130 138